Biogen presents at Global Healthcare Conference
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors. A taped version of the webcast is available.
A longtime Biologics manufacturer, Biogen's portfolio includes treatments for spinal muscular atrophy. It is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.